6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or

15d-16 of the Securities Exchange Act of 1934

For the month of April 2024

Commission File Number: 001-39928

_____________________

Sendas Distribuidora S.A.

(Exact Name as Specified in its Charter)

Sendas Distributor S.A.

(Translation of registrant’s name into English)

Avenida Ayrton Senna, No. 6,000, Lote 2, Pal 48959,Anexo A

Jacarepaguá

22775-005 Rio de Janeiro, RJ, Brazil

(Address of principal executive offices)

(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)

Form 20-F:   ý      Form 40-F:   o

(FREE TRANSLATION INTO ENGLISH FROM THE ORIGINAL PREVIOUSLY ISSUED IN PORTUGUESE)
ITR – Interim Financial Information – March 31,2024 – SENDAS DISTRIBUIDORA S.A.
Contents
Corporate Information / Capital Composition	2
Interim financial information
Individual Statements
Balance Sheet - Assets	3
Balance Sheet - Liabilities	4
Statements of Operations	5
Statements of Comprehensive Income	6
Statements of Cash Flows	7
Statements of Changes in Shareholders’ Equity	8
Notes to the Interim Financial Information	9
(FREE TRANSLATION INTO ENGLISH FROM THE ORIGINAL PREVIOUSLY ISSUED IN PORTUGUESE)
---	---
Interim Financial Information – March 31,2024 – SENDAS DISTRIBUIDORA S.A.
Corporate information / Capital composition
Number of Shares	Current year
(Thousands)	03/31/2024
Share Capital
Common	1,351,833
Preferred	-
Total	1,351,833
Treasury Shares
Common	-
Preferred	-
Total	-
(FREE TRANSLATION INTO ENGLISH FROM THE ORIGINAL PREVIOUSLY ISSUED IN PORTUGUESE)
---	---	---
Interim Financial Information - 3/31/2024 - SENDAS DISTRIBUIDORA S.A.
Individual Financial Statements / Balance Sheet - Assets
R (in thousands)
	Current Quarter	Prior year
Account code	3/31/2024	12/31/2023
1	41,711,000	43,177,000
1.01	13,296,000	14,616,000
1.01.01	4,538,000	5,459,000
1.01.03	788,000	1,199,000
1.01.03.01	788,000	1,199,000
1.01.04	6,579,000	6,664,000
1.01.06	1,100,000	1,100,000
1.01.08	291,000	194,000
1.01.08.03	291,000	194,000
1.01.08.03.01	42,000	48,000
1.01.08.03.03	249,000	146,000
1.02	28,415,000	28,561,000
1.02.01	1,125,000	1,155,000
1.02.01.07	194,000	171,000
1.02.01.09	20,000	23,000
1.02.01.09.04	20,000	23,000
1.02.01.10	911,000	961,000
1.02.01.10.04	551,000	573,000
1.02.01.10.05	41,000	44,000
1.02.01.10.06	201,000	226,000
1.02.01.10.07	118,000	118,000
1.02.02	786,000	864,000
1.02.02.01	786,000	864,000
1.02.02.01.03	786,000	864,000
1.02.03	13,131,000	13,148,000
1.02.04	5,171,000	5,172,000
1.02.05	8,202,000	8,222,000

All values are in US Dollars.

(FREE TRANSLATION INTO ENGLISH FROM THE ORIGINAL PREVIOUSLY ISSUED IN PORTUGUESE)
Interim Financial Information - 3/31/2024 - SENDAS DISTRIBUIDORA S.A.
Individual Financial Statements / Balance Sheet - Liabilities
R (in thousands)
	Current Quarter	Prior year
Account code	3/31/2024	12/31/2023
2	41,711,000	43,177,000
2.01	17,361,000	16,425,000
2.01.01	656,000	624,000
2.01.01.01	76,000	84,000
2.01.01.02	580,000	540,000
2.01.02	9,783,000	12,110,000
2.01.02.01	9,783,000	12,110,000
2.01.02.01.01	8,964,000	9,759,000
2.01.02.01.02	819,000	1,459,000
2.01.02.01.03	-	892,000
2.01.03	323,000	298,000
2.01.04	5,439,000	2,115,000
2.01.04.01	498,000	36,000
2.01.04.02	4,941,000	2,079,000
2.01.05	1,160,000	1,278,000
2.01.05.02	1,160,000	1,278,000
2.01.05.02.09	336,000	418,000
2.01.05.02.17	443,000	532,000
2.01.05.02.19	381,000	328,000
2.02	19,652,000	22,122,000
2.02.01	10,519,000	13,069,000
2.02.01.01	1,507,000	1,947,000
2.02.01.02	9,012,000	11,122,000
2.02.02	8,857,000	8,753,000
2.02.02.02	8,857,000	8,753,000
2.02.02.02.05	33,000	38,000
2.02.02.02.09	8,759,000	8,652,000
2.02.02.02.11	65,000	63,000
2.02.04	242,000	263,000
2.02.06	34,000	37,000
2.02.06.02	34,000	37,000
2.03	4,698,000	4,630,000
2.03.01	1,272,000	1,272,000
2.03.02	61,000	56,000
2.03.04	3,369,000	3,309,000
2.03.08	(4,000)	(7,000)

All values are in US Dollars.

(FREE TRANSLATION INTO ENGLISH FROM THE ORIGINAL PREVIOUSLY ISSUED IN PORTUGUESE)
Interim Financial Information - 3/31/2024 - SENDAS DISTRIBUIDORA S.A.
Individual Financial Statements / Statements of Operations
R (in thousands)
	Year to date current year	Year to date prior year
Account code	1/1/2024 to 3/31/2024	1/1/2023 to 3/31/2023
3.01	17,222,000	15,096,000
3.02	(14,420,000)	(12,668,000)
3.03	2,802,000	2,428,000
3.04	(1,988,000)	(1,809,000)
3.04.01	(1,416,000)	(1,306,000)
3.04.02	(205,000)	(206,000)
3.04.05	(383,000)	(309,000)
3.04.05.01	(379,000)	(313,000)
3.04.05.03	(4,000)	4,000
3.04.06	16,000	12,000
3.05	814,000	619,000
3.06	(760,000)	(630,000)
3.06.01	43,000	70,000
3.06.02	(803,000)	(700,000)
3.07	54,000	(11,000)
3.08	6,000	83,000
3.08.01	(27,000)	-
3.08.02	33,000	83,000
3.09	60,000	72,000
3.11	60,000	72,000
3.99
3.99.01
3.99.01.01	0.04475	0.05329
3.99.02
3.99.02.01	0.04465	0.05314

All values are in US Dollars.

(FREE TRANSLATION INTO ENGLISH FROM THE ORIGINAL PREVIOUSLY ISSUED IN PORTUGUESE)
Interim Financial Information - 3/31/2024 - SENDAS DISTRIBUIDORA S.A.
Individual Financial Statements / Statements of Comprehensive Income
R (in thousands)
	Year to date current year	Year to date prior year
Account code	1/1/2024 to 3/31/2024	1/1/2023 to 3/31/2023
4.01	60,000	72,000
4.02	3,000	1,000
4.02.04	5,000	2,000
4.02.06	(2,000)	(1,000)
4.03	63,000	73,000

All values are in US Dollars.

(FREE TRANSLATION INTO ENGLISH FROM THE ORIGINAL PREVIOUSLY ISSUED IN PORTUGUESE)
Interim Financial Information - 3/31/2024 - SENDAS DISTRIBUIDORA S.A.
Individual Financial Statements / Statements of Cash Flows - Indirect method
R (in thousands)
	Year to date current year	Year to date prior year
Account code	1/1/2024 to 3/31/2024	1/1/2023 to 3/31/2023
6.01	457,000	24,000
6.01.01	1,345,000	1,187,000
6.01.01.01	60,000	72,000
6.01.01.02	(24,000)	(83,000)
6.01.01.03	4,000	(6,000)
6.01.01.04	399,000	336,000
6.01.01.05	775,000	694,000
6.01.01.07	(16,000)	(12,000)
6.01.01.08	2,000	57,000
6.01.01.10	5,000	9,000
6.01.01.11	(1,000)	-
6.01.01.13	141,000	120,000
6.01.02	(888,000)	(1,163,000)
6.01.02.01	417,000	9,000
6.01.02.02	(56,000)	23,000
6.01.02.03	22,000	132,000
6.01.02.04	(114,000)	(88,000)
6.01.02.05	3,000	(48,000)
6.01.02.06	3,000	4,000
6.01.02.07	(1,258,000)	(1,111,000)
6.01.02.08	32,000	(1,000)
6.01.02.09	25,000	(33,000)
6.01.02.10	(27,000)	(14,000)
6.01.02.11	(85,000)	(25,000)
6.01.02.12	56,000	(11,000)
6.01.02.15	94,000	-
6.02	(405,000)	(534,000)
6.02.02	(409,000)	(527,000)
6.02.03	(7,000)	(22,000)
6.02.04	-	15,000
6.02.09	11,000	-
6.03	(973,000)	(1,198,000)
6.03.01	-	2,000
6.03.02	500,000	-
6.03.03	(25,000)	(39,000)
6.03.04	(187,000)	(142,000)
6.03.05	-	(50,000)
6.03.09	(263,000)	(151,000)
6.03.10	(101,000)	(238,000)
6.03.11	(3,000)	(10,000)
6.03.12	(894,000)	(570,000)
6.05	(921,000)	(1,708,000)
6.05.01	5,459,000	5,842,000
6.05.02	4,538,000	4,134,000

All values are in US Dollars.

(FREE TRANSLATION INTO ENGLISH FROM THE ORIGINAL PREVIOUSLY ISSUED IN PORTUGUESE)
Interim Financial Information - 3/31/2024 - SENDAS DISTRIBUIDORA S.A.
Individual Financial Statements / Statements of Changes in Shareholders' Equity 1/1/2024 to 3/31/2024 R (in thousands)
Account code	Capital stock	Capital reserves, granted options and treasury shares	Profit reserves	Retained earnings<br><br>/Accumulated losses	Other comprehensive income	Shareholders' equity
5.01	1,272,000	56,000	3,309,000	-	(7,000)	4,630,000
5.03	1,272,000	56,000	3,309,000	-	(7,000)	4,630,000
5.04	-	5,000	-	-	-	5,000
5.04.03	-	5,000	-	-	-	5,000
5.05	-	-	-	60,000	3,000	63,000
5.05.01	-	-	-	60,000	-	60,000
5.05.02	-	-	-	-	3,000	3,000
5.05.02.07	-	-	-	-	5,000	5,000
5.05.02.09	-	-	-	-	(2,000)	(2,000)
5.06	-	-	60,000	(60,000)	-	-
5.06.05	-	-	60,000	(60,000)	-	-
5.07	1,272,000	61,000	3,369,000	-	(4,000)	4,698,000
Individual Financial Statements / Statements of Changes in Shareholders' Equity 1/1/2023 to 3/31/2023 R (in thousands)
Account code	Capital stock	Capital reserves, granted options and treasury shares	Profit reserves	Retained earnings<br><br>/Accumulated losses	Other comprehensive income	Shareholders' equity
5.01	1,263,000	36,000	2,599,000	-	(2,000)	3,896,000
5.03	1,263,000	36,000	2,599,000	-	(2,000)	3,896,000
5.04	2,000	9,000	-	-	-	11,000
5.04.01	2,000	-	-	-	-	2,000
5.04.03	-	9,000	-	-	-	9,000
5.05	-	-	-	72,000	1,000	73,000
5.05.01	-	-	-	72,000	-	72,000
5.05.02	-	-	-	-	1,000	1,000
5.05.02.07	-	-	-	-	2,000	2,000
5.05.02.09	-	-	-	-	(1,000)	(1,000)
5.06	-	-	72,000	(72,000)	-	-
5.06.05	-	-	72,000	(72,000)	-	-
5.07	1,265,000	45,000	2,671,000	-	(1,000)	3,980,000

All values are in US Dollars.

1	CORPORATE INFORMATION
	Sendas Distribuidora S.A. (“Company”<br> or “Sendas”) is a publicly held company listed in the Novo Mercado segment of B3 S.A. - Brasil, Bolsa, Balcão<br> (B3), under ticker symbol "ASAI3" and on the New York Stock Exchange (NYSE), under ticker symbol "ASAI". The<br> Company is primarily engaged in the retail and wholesale of food products, bazaar items and other products through its chain of stores,<br> operated under “ASSAÍ” brand, since this is the only disclosed segment. The Company's registered office is at<br> Avenida Ayrton Senna, 6.000, Lote 2 - Anexo A, Jacarepaguá, in the State of Rio de Janeiro. As of March 31, 2024, the Company<br> operated 292 stores (288 stores as of December 31, 2023) and 11 distribution centers (11 distribution centers as of December 31,<br> 2023) in the five regions of the country, with operations in 24 states and in the Federal District.
2	BASIS OF PREPARATION AND<br> DISCLOSURE OF THE INTERIM FINANCIAL INFORMATION
	The interim financial<br> information has been prepared in accordance with IAS 34 – Interim Financial Reporting issued by the International Accounting<br> Standards Board (“IASB”) and accounting standard CPC 21 (R1) – Interim Financial Report and disclosed aligned with<br> the standards approved by the Brazilian Securities and Exchange Commission (“CVM”), applicable to the preparation of<br> the Interim Financial Information.
	The interim financial<br> information has been prepared based on the historical cost basis, except for: (i) certain financial instruments; and (ii) assets<br> and liabilities arising from business combinations measured at their fair values, when applicable. In accordance with OCPC 07 - Presentation<br> and Disclosures in General Purpose - Financial Statements, all significant information related to the interim financial information,<br> and only them, is being disclosed and is consistent with the information used by Management in managing of the Company's activities.
	The interim financial<br> information is presented in millions of Brazilian Reais (R), which is the Company's functional currency.
	The interim financial information for<br> the period ended March 31, 2024 were approved by the Board of Directors on April  24, 2024.
3	MATERIAL ACCOUNTING POLICIES
	The material accounting<br> policies and practices applied by the Company to the preparation of the interim financial information are in accordance with those<br> adopted and disclosed in note 3 and in each explanatory note corresponding to the financial statements for the year ended December<br> 31, 2023, approved on February  21, 2024 and, therefore, it should be read together.
3.1	Standards, amendments<br> and interpretations
	In the period ended March 31, 2024, the new current standards,<br>include the review of CPC 09 (R1) – Statements of Value Added, were evaluated and produced no effect on the interim financial information<br>disclosed, additionally the Company did not adopt in advance the IFRS issued and not yet current.
4	SIGNIFICANT ACCOUNTING<br> JUDGMENTS, ESTIMATES AND ASSUMPTIONS
	The preparation of<br> the interim financial information requires Management to makes judgments and estimates and adopt assumptions that affect the reported<br> amounts of revenues, expenses, assets and liabilities, and the disclosure of contingent liabilities at the end of the reporting period,<br> however, the uncertainties about these assumptions and estimates may generate results that require substantial adjustments to the<br> carrying amount of the asset or liability in future periods.
	The significant assumptions<br> and estimates applied on the preparation of the interim financial information for the period ended March 31, 2024, were the same<br> as those adopted in the financial statements for the year ended December 31, 2023, approved on February 21, 2024, disclosed in note<br> 5.
5	CASH AND CASH EQUIVALENTS
		12/31/2023
	Cash<br> and bank accounts	352
	Cash<br> and bank accounts - Abroad (i)		22
	Financial<br> investments (ii)		5,085
		5,459
	(i) As of March 31,<br> 2024, the Company had funds held abroad, of which R23 in US dollars (R22 in US dollars as of December 31, 2023).
	(ii) As of March 31, 2024, the financial<br> investments refer to the repurchase and resale agreements and Bank Deposit Certificates - CDB, with a weighted average interest rate<br> of 97.17% of the CDI - Interbank Deposit Certificate (95.92% of the CDI as of December 31, 2023).
	The Company's exposure<br> to interest rate indexes and the sensitivity analysis for these financial assets are disclosed in note 15.3.

All values are in US Dollars.

6	TRADE<br> RECEIVABLES
				Note		3/31/2024		12/31/2023
	From sales with:
	Credit card			6.1		354		589
	Credit card<br> - related parties			9.1		86		211
	Ticket and slips			6.1 and 6.2		300		333
	Suppliers and<br> others					62		81
						802		1,214
	Expected credit<br> loss for doubtful accounts			6.3		-	(14)	(15)
						788		1,199
	The breakdown of trade<br> receivables by their gross amount by maturity period is presented below:
						Overdue
		Total		Due		Less<br> than 30 days		Over<br> 30 days
	March 31, 2024		802		794	4		4
	December 31, 2023		1,214		1,202	5		7
6.1	Assignment<br> of receivables
	The Company assigned<br> part of its receivables referring to credit cards and tickets with operators, without any right of recourse, aiming to anticipate<br> its cash flow. As of March 31, 2024, the volume of these operations is R2,649 (R2,757 as of December 31, 2023). The amount was<br> derecognized from the balance of trade receivables, since all risks related to the receivables were substantially transferred. The<br> cost to advance these credit card receivables is classified as “Cost and discount of receivables” in note 23.
6.2	Tickets<br> and slips
	Refers to amounts derived<br> from transactions through receipts: (i) tickets and meal vouchers R185 (R185 as of December 31, 2023); and (ii) payment slips R115<br> (R148 as of December 31, 2023).
6.3	Expected<br> credit loss for doubtful accounts
		3/31/2024		3/31/2023
	At the beginning of the period	(15)		(11)
	Additions	(25)		(8)
	Reversals	26		10
	At the end of the period	(14)		(9)
7	INVENTORIES
		3/31/2024		3/31/2023
	Stores	5,960		6,033
	Distribution centers	1,173		1,237
	Commercial agreements	(509)		(525)
	Inventory losses	(45)		(81)
		6,579		6,664
7.1	Commercial<br> agreements
	As<br> of March 31, 2024, the amount of unrealized commercial agreements, presented as a reduction of inventory balance, totaled R509 (R525<br> as of December 31, 2023).
7.2	Inventory<br> losses
		3/31/2024		3/31/2023
	At the beginning of the period	(81)		(68)
	Additions	(146)		(126)
	Reversals	5		6
	Write-offs	177		144
	At the end of the period	(45)		(44)

All values are in US Dollars.

8	RECOVERABLE<br> TAXES
			Note	3/31/2024	12/31/2023
	ICMS		8.1	1,006	1,085
	PIS<br> and COFINS		8.2	320	287
	Social<br> Security Contribution - INSS			183	169
	Whithholding<br> taxes to be recovered			137	105
	Others			5	27
				1,651	1,673
	Current			1,100	1,100
	Non-current			551	573
8.1	State<br> VAT tax credits - ICMS
	The Brazilian States<br> have been substantially amending their local laws aiming at implementing and broadening the ICMS tax replacement system. This system<br> entails the prepayment of ICMS of the whole commercial chain, upon goods outflow from an industrial establishment or importer or<br> their inflow into each State. The expansion of this system to an increasingly wider range of products sold in the retail generates<br> the prepayment of the tax and consequently a refund in certain operations.
	With respect to credits<br> that cannot yet be immediately offset, the Company's management, according to a technical recovery study, based on the future expectation<br> of growth and consequent offset against taxes payable from its operations, believes that its future offset is viable. The mentioned<br> studies are prepared and periodically reviewed based on information obtained from the strategic planning previously approved by the<br> Company's Board of Directors. For the interim financial information as of March 31, 2024, the Company's management has monitoring<br> controls over the adherence to the annually established plan, reassessing and including new elements that contribute to the realization<br> of the recoverable ICMS balance, as shown in the table below:
	Year
	Within<br> 1 year	496
	From<br> 1 to 2 years	111
	From<br> 2 to 3 years	110
	From<br> 3 to 4 years	87
	From<br> 4 to 5 years	54
	More<br> than 5 years	148
		1,006
8.2	PIS and<br> COFINS credit
	On March 15, 2017, the<br> Federal Supreme Court  ("STF”) recognized the unconstitutionality of the inclusion of ICMS in the PIS and COFINS<br> calculation base. On May 13, 2021, the STF judged the Declaration Embargoes in relation to the amount to be excluded from the calculation<br> basis of the contributions, which should only be the ICMS paid, or if the entire ICMS, as shown in the respective invoices. The STF<br> rendered a favorable decision to the taxpayers, concluding that all ICMS highlighted should be excluded from the calculation basis.
	Currently the Company,<br> with the favorable judgment of the Supreme Court, has recognized the exclusion of ICMS from the PIS and COFINS calculation basis.
	In addition to the recorded<br> credits, the Company has contingent tax assets in the amount of R54 related to PIS and COFINS credits.
	•<br> Expected realization of PIS and COFINS credits
	In relation to the recoverable PIS and COFINS credits, the Company's management, based on a technical recovery study considering future growth expectations and consequent offset against debts from its operations, projects its future realization. The mentioned studies are prepared and periodically reviewed based on information obtained from the strategic planning previously approved by the Company's Board of Directors. For the interim financial information as of March 31, 2024, the Company's management has monitoring controls over the adherence to the annually established plan, reassessing and including new elements that contribute to the realization of the recoverable PIS and COFINS balance, in the amount of R320, and expected realization is within one year.

All values are in US Dollars.

9	RELATED<br> PARTIES
9.1	Balances<br> and related party transactions
		Assets				Liabilities		Transactions
		Trade<br> receivables		Other<br> assets		Suppliers		Revenue<br> (expenses)
		3/31/2024	12/31/2023	3/31/2024	12/31/2023	3/31/2024	12/31/2023	3/31/2024	3/31/2023
	Joint venture
	Financeira<br> Itaú CBD S.A. Crédito, Financiamento e Investimento (“FIC”)	86	211	20	23	25	28	7	6
		86	211	20	23	25	28	7	6
	Current	86	211	-	-	25	28
	Non-current	-	-	20	23	-	-
		Transactions
		Revenue<br> (expenses)
		3/31/2023
	Associates (i)
	Casino<br> Guichard Perrachon	(16)
	Euris	(1)
	Grupo<br> Pão de Açúcar ("GPA")	(3)
	Wilkes<br> Participações S.A.	(2)
		(22)
	(i)<br> On June 23, 2023, as per the Notice to the Market published on the same date, Casino, through its subsidiaries Wilkes, Geant International<br> BV ("GIBV") and Segisor S.A.S ("Segisor"), sold 157,582,850 common shares issued by the Company, representing<br> 11.67% of its share capital, through a block trade operation carried out on the same date. As a result, the Casino Group now holds<br> an ownership interest of less than 0.01% of Sendas' share capital, no longer being considered a related party of the Company. The<br> balances with these companies and their subsidiaries are presented under the line items Other accounts receivable and Other accounts<br> payable in the balance sheet in the interim financial information for the period ended March 31, 2024.
9.2	Management<br> compensation
---	---	---	---	---	---	---	---	---	---	---
	Expenses<br> referring to the executive board compensation recorded in the Company’s statement of operations in the period ended March 31,<br> 2024 and 2023 as follows (amounts expressed in thousands reais):
			Base<br> salary		Variable<br> compensation		Stock<br> option plan and shared-based payment plan (i)		Total
			2024	2023	2024	2023	2024	2023	2024	2023
	Board of directors		3,048	2,722	-	-	-	5,154	3,048	7,876
	Statutory officers		3,562	2,809	5,562	3,722	4,890	3,017	14,014	9,548
	Executives excluding statutory officers		8,607	7,302	17,804	9,579	4,371	2,552	30,782	19,433
	Fiscal council		141	130	-	-	-	-	141	130
			15,358	12,963	23,366	13,301	9,261	10,723	47,985	36,987
	(i) More details about<br> shared-based payment plan for the Statutory officers, see note 19.3.3.
	The stock option plan,<br> fully in shares, refers to the Company's and this plan has been treated in the Company's statement of operations. The corresponding<br> expenses are allocated to the Company and recorded in the statement of operations against capital reserve - stock options in shareholders'<br> equity. There are no other short-term or long-term benefits granted to members of the Company's management.
10	INVESTMENTS
	The details of the Company's<br> investments at the end of the period are as follows:
							Participation<br> in investments - %
							Direct<br> participation
	Investment<br> type	Company				Country	3/31/2024		12/31/2023
	Joint venture	Bellamar Empreendimento<br> e Participações S.A.				Brazil	50.00		50.00
	Summary<br> of financial information of Joint Venture
			3/31/2024		12/31/2023
	Current assets		1		1
	Non-current assets		426		581
	Shareholders´<br> equity		427		582
			3/31/2024		3/31/2023
	Net income for the<br> period		32		24
	Investments<br> composition and breakdown
			Bellamar
	As of December 31,<br> 2022		833
	Share<br> of profit of associates		12
	Dividends<br> receivables		(7)
	As of March 31, 2023		838
	As of December 31, 2023		864
	Share<br> of profit of associates		16
	Dividends<br> received		(94)
	As of March 31, 2024		786
11	PROPERTY,<br> PLANT AND EQUIPMENT
---	---	---	---	---	---	---	---	---	---	---
11.1	Breakdown<br> and composition of property, plant and equipment
		As<br> of 12/31/2023	Additions<br> (i)	Write-off	Depreciation	Transfers<br> and others	As<br> of <br><br> 3/31/2024		Historical<br> cost	Accumulated<br> depreciation
	Lands	559	-	-	-	-	559	=	559	-
	Buildings	777	31	-	(5)	41	844		1,006	(162)
	Improvements	8,099	93	(1)	(124)	(32)	8,035		9,643	(1,608)
	Machinery and equipment	2,310	71	-	(65)	6	2,322		3,361	(1,039)
	Facilities	270	2	-	(9)	-	263		432	(169)
	Furniture and appliances	903	29	(2)	(39)	5	896		1,342	(446)
	Constructions in progress	111	5	-	-	(20)	96		96	-
	Others	119	8	-	(13)	2	116		265	(149)
		13,148	239	(3)	(255)	2	13,131		16,704	(3,573)
		As<br> of 12/31/2022	Additions<br> (i)	Write-off	Depreciation	Transfers<br> and others	As<br> of<br><br> 3/31/2023		Historical<br> cost	Accumulated<br> depreciation
	Lands	600	-	-	-	(41)	559	=	559	-
	Buildings	730	-	-	(5)	(2)	723		856	(133)
	Improvements	6,865	352	(11)	(99)	27	7,134		8,299	(1,165)
	Machinery and equipment	1,440	87	(10)	(68)	140	1,589		2,371	(782)
	Facilities	585	30	(1)	(12)	-	602		758	(156)
	Furniture and appliances	755	26	(1)	(24)	63	819		1,129	(310)
	Constructions in progress	543	16	-	-	(250)	309		309	-
	Others	64	8	-	(5)	34	101		199	(98)
		11,582	519	(23)	(213)	(29)	11,836		14,480	(2,644)
	(i) Includes interest<br> capitalization in the amount of R15 (R91 as of March 31, 2023), see note 11.2.

All values are in US Dollars.

11.2	Capitalized borrowing<br> costs and lease
	The value of capitalized<br> borrowing costs and lease directly attributable to the reform, construction and acquisition of property, plant and equipment and<br> intangible assets within the scope of CPC 20 (R1)/IAS 23 - Borrowing Costs and the amount of interest on lease liabilities incorporated<br> into the value of the property, plant and equipment and/or intangible assets, for the period in which the assets are not yet in their<br> intended use in accordance with CPC 06 (R2)/IFRS 16 - Leases, amounted to R15 (R91 as of March 31, 2023). The rate used to calculate<br> the borrowing costs eligible for capitalization was 113.41% (110.62% as of March 31, 2023) of CDI, corresponding to the effective<br> interest rate of borrowings taken by the Company.
11.3	Additions to property,<br> plant and equipment for cash flow purpose
		3/31/2023
	Additions	519
	Capitalized borrowing costs	(91)
	Financing of property,<br> plant and equipment - Additions	(435)
	Financing of property,<br> plant and equipment - Payments	534
		527
	Additions related to the purchase of operating<br> assets, purchase of land and buildings to expansion activities, building of new stores and distribution centers, improvements of<br> existing distribution centers and stores and investments in equipment and information technology.
	The additions and payments of property,<br> plant and equipment above are presented to reconcile the acquisitions during the period with the amounts presented in the statement<br> of cash flows net of items that did not impact cash flow.
11.4	Other information
	As of March 31, 2024, the Company recorded<br> in the cost of sales and services the amount of R20 (R23 as of March 31, 2023), relating to the depreciation of machinery, buildings<br> and facilities of distribution centers.
11.5	Impairment test of property,<br> plant and equipment
	The impairment test<br> of property, plant and equipment uses the same practices described in note 12.1 to the financial statements as of December 31, 2023.
	The Company monitored<br> the plan used to assess impairment test as of December 31, 2023, and concluded that there is no events which could indicate losses<br> or the need for a new evaluation for the period ended March 31, 2024.

All values are in US Dollars.

12	INTANGIBLE
12.1	Breakdown and composition of intangible assets
		As<br> of 12/31/2023	Additions	Write-off	Amortization	As<br> of 3/31/2024				Historical<br> cost	Accumulated<br> amortization
	Goodwill	618	-	-	-	618				871	(253)
	Software	63	7	(1)	(5)	64		=		186	(122)
	Commercial rights	4,452	-	-	(2)	4,450			4,491		(41)
	Trade name	39	-	-	-	39			39		-
		5,172	7	(1)	(7)	5,171			5,587		(416)
		As<br> of 12/31/2022	Additions	Amortization	As<br> of 3/31/2023		Historical<br> cost			Accumulated<br> amortization
	Goodwill	618	-	-	618	=	871			(253)
	Software	76	5	(4)	77		156			(79)
	Commercial rights	4,267	17	(2)	4,282		4,317			(35)
	Trade name	39	-	-	39		39			-
		5,000	22	(6)	5,016		5,383			(367)
12.2	Impairment test of intangible<br> assets with indefinite useful life, including goodwill
---	---
	The impairment test<br> of intangible assets uses the same practices described in note 12.1 to the financial statements as of December 31, 2023.
	The Company monitored<br> the plan used to assess impairment test as of December 31, 2023, and concluded that there is no events which could indicate losses<br> or the need for a new evaluation for the period ended March 31, 2024.
12.3	Commercial<br> rights
	Commercial rights<br> with defined and indefinite useful lives are tested following the assumptions described in note 12.1.1, to the financial statements<br> as of December 31, 2023. The Company considered the discounted cash flow of the related store for the impairment test, that is, the<br> store is the CGU.
	The Company monitored<br> the plan used to assess impairment test as of December 31, 2023, and concluded that there is no events which could indicate losses<br> or the need for a new evaluation for the period ended March 31, 2024.
13	LEASES
---	---	---	---	---	---	---	---	---	---	---	---	---	---
13.1	Right-of-use
13.1.1	Breakdown<br> and composition of right-of-use assets
		As<br> of 12/31/2023	Additions	Remeasurement	Amortization	Transfers<br> and others	As<br> of 3/31/2024		Historical<br> cost			Accumulated<br> amortization
	Buildings	8,203	1	118	(136)	(2)	8,184	=	9,989			(1,805)
	Equipment	3	-	-	(1)	-	2		44			(42)
	Assets and rights	16	-	-	-	-	16		28			(12)
		8,222	1	118	(137)	(2)	8,202		10,061			(1,859)
		As<br> of 12/31/2022	Additions	Remeasurement	Write-off	Amortization	Transfers<br> and others	As<br> of 3/31/2023			Historical<br> cost		Accumulated<br> amortization
	Buildings	7,593	27	162	(110)	(115)	(12)	7,545		=	8,972		(1,427)
	Equipment	8	-	-	-	(1)	-	7			56		(49)
	Assets and rights	18	-	-	-	(1)	-	17			28		(11)
		7,619	27	162	(110)	(117)	(12)	7,569			9,056		(1,487)
13.2	Lease<br> liabilities
---	---	---	---	---	---	---
13.2.1	Minimum<br> future payments and potential right of PIS and COFINS
	Lease contracts totaled<br> R9,202 as of March 31, 2024 (R9,184 as of December 31, 2023). The minimum future lease payments, according to lease agreements,<br> with the present value of minimum lease payments, are as follows:
			3/31/2024		12/31/2023
	Lease<br> liabilities - minimum payments
	Less<br> than 1 year		443		532
	From<br> 1 to 5 years		1,734		1,702
	More<br> than 5 years		7,025		6,950
	Present<br> value of lease liabilities		9,202		9,184
	Current		443		532
	Non-current		8,759		8,652
	Future<br> financing charges		13,098		13,164
	Gross<br> amount of financial lease agreements		22,300		22,348
	PIS<br> and COFINS embedded in the present value of lease agreements			559		558
	PIS<br> and COFINS embedded in the gross value of lease agreements			1,356		1,359
	Lease liabilities interest<br> expense is stated in note 23. The Company´s average incremental interest rate at the agreement signing date was 12.13% in the<br> period ended March 31, 2024 (12.12% as of December 31, 2023).
	Had the Company adopted<br> the calculation methodology projecting the inflation embedded in the nominal incremental rate and discounted to present value at<br> the nominal incremental rate, the average percentage of inflation to be projected by year would be approximately 6.66% (6.72% as<br> of December 31, 2023). The average term of the agreements analyzed as of March 31,2024 and December 31, 2023is 18 years.
13.2.2	Lease<br> liability roll forward
			Amount
	As of December 31,<br> 2022		8,360
	Addition<br> - Lease		27
	Remeasurement		162
	Interest<br> provision		239
	Principal<br> amortization		(151)
	Interest<br> amortizations		(238)
	Write-off<br> due to early termination of agreement		(120)
	As of March 31, 2023		8,279
			Amount
	As of December 31,<br> 2023		9,184
	Addition<br> - Lease			1
	Remeasurement			118
	Interest<br> provision			263
	Principal<br> amortization			(101)
	Interest<br> amortizations			(263)
	As of March 31, 2024		9,202
13.3	Result<br> on variable rentals and subleases
			3/31/2023
	(Expenses) revenues of the period:
	Variables (1% to 2%<br> of sales)		(6)
	Subleases (i)	26		21
	(i) Refers mainly<br> to the revenue from lease agreements receivable from commercial galleries.

All values are in US Dollars.

13.4	Additional<br> information
	In accordance with OFÍCIO-CIRCULAR/CVM/SNC/SEP/N°02/2019<br> the Company adopted as an accounting policy the requirements of CPC 06 (R2)/IFRS16 - Leases, in the measurement and remeasurement<br> of its right of use, using the discounted cash flow model, without considering inflation.
	To safeguard the faithful<br> representation of information to meet the requirements of CPC 06 (R2)/IFRS16 - Leases, and the guidelines of the CVM technical areas,<br> the balances of assets and liabilities without inflation, effectively accounted for (real flow x real rate) are provided, and the<br> estimate of inflated balances in the comparison period (nominal flow x nominal rate).
	Other assumptions, such<br> as the maturity schedule of liabilities and the interest rates used in the calculation, are disclosed in note 13.2.1, as well as<br> inflation indexes are observable in the market, so that the nominal flows can be prepared by the users of the interim financial information.
				3/31/2024	12/31/2023
	Real flow
	Right-of-use assets			8,203	8,222
	Lease liabilities			22,300	22,348
	Embedded interest			(13,098)	(13,164)
				9,202	9,184
	Inflated flow
	Right-of-use assets			12,829	12,776
	Lease liabilities			35,780	35,568
	Embedded interest			(19,387)	(19,354)
				16,393	16,214
		Below we present the<br> flow of payments according to the average term weighted with the respective nominal and inflation rates for each period presented:
	As of<br> March 31, 2024
	Year		Amount	Nominal<br> tax	Projected<br> inflation
	Within 1 year		1,406	12.19%	3.11%
	From<br> 1 to 2 years		1,316	12.22%	3.26%
	From<br> 2 to 3 years		1,331	12.25%	3.67%
	From<br> 3 to 4 years		1,314	12.28%	2.69%
	From<br> 4 to 5 years		2,445	12.31%	3.58%
	More<br> than 5 years		14,488	12.52%	3.58%
			22,300
	As of<br> December 31, 2023
	Year		Amount	Nominal<br> tax	Projected<br> inflation
	Within 1 year		1,435	12.19%	4.48%
	From<br> 1 to 2 years		1,300	12.22%	3.86%
	From<br> 2 to 3 years		1,316	12.25%	3.45%
	From<br> 3 to 4 years		1,311	12.28%	3.49%
	From<br> 4 to 5 years		2,437	12.32%	3.58%
	More<br> than 5 years		14,549	12.54%	3.58%
			22,348
14	TRADE PAYABLES AND TRADE<br> PAYABLES - AGREEMENTS
---	---	---	---
		3/31/2024	12/31/2023
	Trade payables
	Products	9,540	10,363
	Acquisition<br> of property, plant and equipment	75	158
	Service	167	150
	Service<br> - related parties	25	28
	Bonuses<br> from suppliers	(810)	(902)
		8,997	9,797
	Trade<br> payables - Agreements
	Products	531	1,070
	Acquisition<br> of property, plant and equipment	288	389
	Acquisition<br> of hipermarkets (i)	-	892
		819	2,351
		9,816	12,148
	Current	9,783	12,110
	Non-current	33	38
	(i) Total settlement<br> in January 2024 in the amount of R894.
14.1	Bonuses from suppliers
	These include commercial agreements and<br> discounts obtained from suppliers. These amounts are defined in agreements and include discounts for purchase volume, joint marketing<br> programs, freight reimbursements, and other similar programs. The receipt occurs by deducting trade notes payable to suppliers, according<br> to conditions established in the supply agreements, so that the financial settlements occur for the net amount.
14.2	Agreements<br> among suppliers, the Company and banks
	The Company has agreements signed with<br> financial institutions, through which suppliers of products, capital goods and services have the possibility of receiving in advance<br> their amounts receivable,  also named “forfait” / “confirming”.  The financial institutions<br> become creditors of the operation and the Company settles the payments under the same conditions as those originally agreed with<br> the supplier.
	Management, based on CPC 3 (R2)/IAS 7<br> and CPC 40 (R1)/IFRS 7, assessed that the economic substance of the transaction is operational, considering that receiving in advance<br> is an exclusive decision of the supplier and, for the Company, there are no changes in the original term negotiated with the supplier,<br> nor changes in the originally contracted amounts. These transactions aim at facilitating the cash flow of its suppliers without the<br> Company having to advancing payments. Management evaluated the potential effects of adjusting these operations to present value and<br> concluded that the effects are immaterial for measurement and disclosure.
	These balances are classified as "Trade<br> payables - Agreements" and the cash flow from these operations is presented as operating in the statement of cash flows.
	Additionally, there is no exposure to<br> any financial institution individually related to these operations and these liabilities are not considered net debt and do not have<br> restrictive covenants (financial or non-financial). In these transactions, the Company earns income referring to the premium for<br> referring suppliers to the operations of advance of receivables, recognized in the financial result, note 23 in the line "Revenue<br> from antecipation of payables", in the amount of R15 as of March 31, 2024 (R8 as of March 31, 2023), representing 1.47% of<br> the volume of transactions occurred during 2024 (0.79% during 2023).
	As of March 31, 2024, the balance payable<br> related to these operations is R819 (R1,459 as of December 31, 2023).
	The balances of trade payables and trade<br> payables – agreement are similar and do not exceed the expiration date of 120 days as of March 31, 2024.

All values are in US Dollars.

15	FINANCIAL INSTRUMENTS
	The main financial instruments and their<br> amounts ​​recorded in the interim financial information, by category, are as follows:
		Note	Amortized<br> cost	Fair<br> value	FVTOCI<br> (i)	As<br> of 3/31/2024
	Financial assets
	Cash<br> and cash equivalents	5	4,538	-	-	4,538
	Related<br> parties	9.1	20	-	-	20
	Trade<br> receivables and other accounts receivables		333	-	-	333
	Gain<br> on financial instruments at fair value	15.5.1	-	243	-	243
	Trade<br> receivables with credit card and tickets		-	-	625	625
	Financial liabilities
	Other<br> accounts payable		(252)	-	-	(252)
	Trade<br> payables and trade payables - agreements	14	(9,816)	-	-	(9,816)
	Borrowings	15.5.1	(1,967)	-	-	(1,967)
	Debentures<br> and promissory notes	15.5.1	(10,780)	-	-	(10,780)
	Lease<br> liabilities	13.2	(9,202)	-	-	(9,202)
	Borrowings<br> and debentures	15.5.1	-	(3,209)	-	(3,209)
	Loss<br> of financial instruments at fair value	15.5.1	-	(2)	-	(2)
	Net exposure		(27,126)	(2,968)	625	(29,469)
		Note	Amortized<br> cost	Fair<br> value	FVTOCI<br> (i)	As<br> of 12/31/2023
	Financial assets
	Cash<br> and cash equivalents	5	5,459	-	-	5,459
	Related<br> parties	9.1	23	-	-	23
	Trade<br> receivables and other accounts receivables		396	-	-	396
	Gain<br> on financial instruments at fair value	15.5.1	-	274	-	274
	Trade<br> receivables with credit card and tickets		-	-	985	985
	Financial liabilities
	Other<br> accounts payable		(216)	-	-	(216)
	Trade<br> payables and trade payables - agreements	14	(12,148)	-	-	(12,148)
	Borrowings	15.5.1	(1,943)	-	-	(1,943)
	Debentures<br> and promissory notes	15.5.1	(10,051)	-	-	(10,051)
	Lease<br> liabilities	13.2	(9,184)	-	-	(9,184)
	Borrowings<br> and debentures	15.5.1	-	(3,182)	-	(3,182)
	Loss<br> of financial instruments at fair value	15.5.1	-	(8)	-	(8)
	Net exposure		(27,664)	(2,916)	985	(29,595)
	(i) Fair Value through Other Comprehensive<br> Income.
	The fair value of other financial instruments<br> detailed in the table above approximates the carrying amount based on the existing payment terms and conditions. The financial instruments<br> measured at amortized cost, the fair values of wich differ from the carrying amounts, are disclosed in note 15.4.
15.1	Considerations on risk<br> factors that may affect the business of the Company
15.1.1	Credit risk
	•<br> Cash and cash equivalents
	In order to minimize the credit risk,<br> the investment policies adopted establish investiments in financial institutions approved by the Company’s Financial Committee,<br> considering the monetary limits and evaluations of financial institutions, which are regularly updated.
	The Company's financial investments, according<br> to the rating on the national scale of financial institutions, are 100% represented by brAAA.
	•<br> Trade receivables
	The credit risk related to trade receivables<br> is minimized by the fact that a large part of installment sales are made with credit cards. These receivables may be advanced at<br> any time, without right of recourse, with banks or credit card companies, for the purpose of providing working capital, generating<br> the derecognition of the accounts receivable. In addition, the main acquirers used by the Company are related to first-tier financial<br> institutions with low credit risk. Additionally, for trade receivables collected in installments, the Company monitors the risk for<br> the granting of credit and for the periodic analysis of the expected credit loss balances.
	The Company also incurs counterparty risk<br> related to derivative instruments. This risk is mitigated by carrying out transactions, according to policies approved by governance<br> bodies.
	There are no amounts receivable that individually<br> account for more than 5% of the accounts receivable or revenues.
15.1.2	Interest<br> rate risk
---	---	---	---	---	---	---	---	---
	The Company obtains borrowings<br> with major financial institutions to meet cash requirements for investments. Accordingly, the Company is mainly exposed to the risk<br> of significant fluctuations in the interest rate, especially the rate related to derivative liabilities (foreign currency exposure<br> hedge) and debts indexed to CDI. The balance of cash and cash equivalents, indexed to CDI, partially offsets the risk of fluctuations<br> in the interest rates.
15.1.3	Capital<br> risk management
	The main objective of<br> the Company’s capital management is to ensure that the Company maintains its credit rating and a well-balanced equity ratio,<br> in order to support businesses and maximize shareholder value. The Company manages the capital structure and makes adjustments considering<br> the changes in the economic conditions.
	The capital structure<br> is as follows:
		3/31/2024		12/31/2023
	Borrowings, debentures and promissory<br> notes	(15,958)		(15,184)
	(-) Cash and cash equivalents	4,538		5,459
	(-) Derivative financial instruments	243		274
	Net debt	(11,177)		(9,451)
	Shareholders’ equity	4,698		4,630
	% Net debt to shareholders’ equity	238%		204%
15.1.4	Liquidity<br> risk management
	The<br> Company manages liquidity risk through daily monitoring of cash flows and control of maturities of financial assets and liabilities.
	The table below summarizes<br> the aging profile of the Company’s financial liabilities as of March 31, 2024.
		Less<br> than 1 year		From<br> 1 to 5 years		More<br> than 5 years		Total
	Borrowings		746	1,623		-		2,369
	Debenture and promissory notes		5,979	10,857		1,199		18,035
	Derivative financial instruments		91	(262)		(337)		(508)
	Lease liabilities		1,406	6,406		14,488		22,300
	Trade payables		8,964	39		-		9,003
	Trade payables - Agreements		819	-		-		819
	Other accounts payable		205	-		47		252
		18,210		18,663		15,397		52,270
	The<br> information was prepared considering the undiscounted cash flows of financial liabilities based on the earliest date the Company<br> may be required to make the payment or be eligible to receive the payment. To the extent that interest rates are floating, the undiscounted<br> amount is obtained based on interest rate curves for the period ended March 31, 2024. Therefore, certain balances presented do not<br> agree with the balances presented in the balance sheets.
15.2	Derivative<br> financial instruments
					Fair<br> value
			12/31/2023		3/31/2024		12/31/2023
	Swap of hedge
	Hedge<br> purpose (debt)		2,956		3,131		3,230
	Long Position
	Fixed<br> rate		106		42		110
	Hedge<br> - CRI		2,850		3,089		3,120
	Short Position		(2,956)		(2,890)		(2,964)
	Net hedge position		-		241		266
	Realized<br> and unrealized gains and losses on these contracts during the period ended March 31, 2024 are recorded as net financial results and<br> the balance receivable at fair value is R241 (balance receivable of R266 as of December 31, 2023). The assets are recorded as “derivative<br> financial instruments” and the liabilities as “debentures”.
	The<br> effects of the hedge at fair value through income for the period ended March 31, 2024, resulted in a loss of R45 (gain of R12 as<br> of March 31, 2023), recorded under cost of debt, see note 23.

All values are in US Dollars.

	The consolidated position<br> of outstanding derivative financial instrument transactions is presented in the table below:
	Description		Reference<br> value	Maturity		3/31/2024		12/31/2023
	Debt
	IPCA - BRL		R$1.972	2028,<br> 2029 and 2031		246		267
	Interest rate swaps<br> registered at CETIP
	Pre-fixed rate x CDI		R$879	2027		(9)		(5)
	Pre-fixed rate x CDI		R$17	2027		2		2
	Pre-fixed rate x CDI		R$21	2027		2		2
	Derivatives<br> - Fair value hedge - Brazil					241		266
15.3	Sensitivity analysis of<br> financial instruments
	According to Management's<br> assessment, the possible reasonable changes  scenario considered was, on the maturity date of each transaction, the  market<br> curves (interest) of B3.
	To determine the<br> possible relevant change in the relevant risk variable, Management considered the economic environment in which it operates. Therefore,<br> in scenario  (I) there is no impact on the fair value of financial instruments and the weighted interest rate (CDI) was<br> 9.84%  per year. For scenarios (II) and (III), for the exclusive purpose of sensitivity analysis, Management considered<br> a deterioration of 5% and 10%, respectively, in the risk variables, up to one year of the financial instruments, with the aim of<br> demonstrating the sensitivity of the Company's results in an adverse scenario.
	In the case of derivative<br> financial instruments (aiming at hedging the financial debt), the variations of the scenarios are accompanied by the respective hedges,<br> indicating that the effects are not significant.
	The Company disclosed<br> the net exposure of the derivative financial instruments, the corresponding financial instruments and certain financial instruments<br> in the sensitivity analysis table below, for each of the mentioned scenarios:
							Market<br> projections
	Transactions	Note	Risk<br><br> (Rate Increase)		As<br> of 3/31/2024		Scenario<br> <br><br> (I)	Scenario<br> <br><br> (II)	Scenario<br> <br><br> (III)
	Borrowings	15.5.1	CDI<br> + 1.75%  per year		(1,975)		(195)	(205)	(215)
	Borrowings (fixed rate)	15.5.1	CDI<br> + 0.20% per year		(38)		(3)	(4)	(4)
	Debentures and promissory<br> notes	15.5.1	CDI<br> + 1.45% per year		(14,124)		(1,398)	(1,467)	(1,537)
	Total net effect (loss)				(16,137)		(1,596)	(1,676)	(1,756)
	Cash equivalents	5	97.17%<br> of the CDI		4,144		408	428	449
	Net exposure loss				(11,993)		(1,188)	(1,248)	(1,307)
15.4	Fair value measurement
	The Company discloses<br> the fair value of financial instruments measured at fair value and of financial instruments measured at amortized cost, the fair<br> value of which differ from the carrying amounts, pursuant to CPC 46/IFRS 13, which address the concepts of measurement and disclosure<br> requirements. The fair value hierarchy levels are defined below:
	Level 1: fair value<br> measurement at the balance sheet date using quoted prices (unadjusted) in active markets for identical assets or liabilities to which<br> the entity may have access at the measurement date.
	Level 2: fair value<br> measurement at the balance sheet date using other significant observable assumptions for the asset or liability, either directly<br> or indirectly, except quoted prices included in Level 1.
	Level 3: fair value<br> measurement at the balance sheet date using non-observable data for the asset or liability.
	The fair values of<br> cash and cash equivalents, trade receivables and trade payables approximate their carrying amounts.
	The table below sets<br> forth the fair value hierarchy of financial assets and liabilities measured at fair value and of financial instruments measured at<br> amortized cost, all classified as level 2, for which the fair value has been disclosed in the interim financial information:
			Carrying<br> amount			Fair<br> value
			3/31/2024	12/31/2023		3/31/2024		12/31/2023
	Trade<br> receivables with credit card and tickets		625	985		625		985
	Interest<br> rate swaps		(5)	(1)		(5)		(1)
	Interest<br> rate swaps - CRI		246	267		246		267
	Borrowings<br> and debentures (fair value)		(3,209)	(3,182)		(3,209)		(3,182)
	Borrowings<br> and debentures (amortized cost)		(12,747)	(11,994)		(12,467)		(11,716)
			(15,090)	(13,925)		(14,810)		(13,647)
	There were no change<br> between fair value measurement hierarchy levels during the period ended March 31, 2024.
	Interest rate swaps<br> and borrowings are classified in Level 2 since the fair value of such financial instruments was determined based on readily observable<br> inputs, such as expected interest rate.
15.5	Borrowings
---	---	---	---	---	---
15.5.1	Debt<br> breakdown
			Average<br> rate	3/31/2024	12/31/2023
	Debentures<br> and promissory notes		CDI<br> + 1.45 % per year	14,124	13,378
	Borrowing<br> costs			(173)	(185)
				13,951	13,193
	Derivative<br> financial instruments - Debentures and promissory notes
	Swap<br> contracts		CDI<br> + 0.80% per year	(239)	(270)
	Swap<br> contracts		CDI<br> + 1.32 % per year	2	8
				(237)	(262)
	Borrowings<br> in domestic currency
	Working<br> capital		CDI<br> + 0.20% per year	38	40
	Working<br> capital		CDI<br> + 1.75% per year	1,975	1,952
	Borrowing<br> costs			(8)	(9)
				2,005	1,983
	Derivative<br> financial instruments - Domestic currency
	Swap<br> contracts		CDI<br> + 0.80% per year	(4)	(4)
				(4)	(4)
	Total of borrowings, debentures and<br> promissory notes			15,715	14,910
	Current asset			(42)	(48)
	Non-current asset			(201)	(226)
	Current liabilities			5,439	2,115
	Non-current liabilities			10,519	13,069
15.5.2	Roll<br> forward of borrowings
		Amount
	Balance as of December<br> 31, 2022	12,409
	Borrowing<br> costs	(10)
	Interest<br> provision	449
	Swap<br> contracts	7
	Mark-to-market	(19)
	Exchange<br> rate and monetary variation	(7)
	Borrowing<br> costs amortization	6
	Interest<br> amortization	(142)
	Principal<br> amortization	(3)
	Swap<br> amortization	(36)
	Balance as of March<br> 31, 2023	12,654
		Amount
	Balance as of December<br> 31, 2023	14,910
	Funding	500
	Borrowing<br> costs	(3)
	Interest<br> provision	459
	Swap<br> contracts	(13)
	Mark-to-market	58
	Borrowing<br> costs amortization	16
	Interest<br> amortization	(187)
	Principal<br> amortizations	(25)
	Balance as of March<br> 31, 2024	15,715
15.5.3	Schedule<br> of non-current maturities
---	---	---	---	---	---	---	---	---	---	---	---
	Maturity		Amount
	From<br> 1 to 2 years		1,797
	From<br> 2 to 3 years		1,569
	From<br> 3 to 4 years		3,905
	From<br> 4 to 5 years		2,097
	More<br> than 5 years		1,075
			10,443
		Borrowing<br> cost	(125)
			10,318
15.6	Debentures<br> and promissory notes
						Date
				Issue<br> amount (in thousands)	Outstanding<br> debentures (units)	Issue	Maturity	Annual<br> financial charges	Unit<br> price (in Reais)	3/31/2024	12/31/2023
	First Issue of Promissory Notes - 5^th^series			200	4	07/04/2019	07/04/2024	CDI + 0.72% per<br> year	74,298,310	297	289
	First Issue of Promissory Notes - 6^th^series			200	4	07/04/2019	07/04/2025	CDI + 0.72% per<br> year	74,298,310	297	289
	Second Issue of Debentures - 1^st^series			940,000	940,000	06/01/2021	05/20/2026	CDI + 1.70% per<br> year	1,045	983	954
	Second Issue of Debentures - 2^nd^series			660,000	660,000	06/01/2021	05/22/2028	CDI + 1.95% per<br> year	1,046	691	670
	Second Issue of Promissory Notes - 1^st^series			1,250,000	1,250,000	08/27/2021	08/27/2024	CDI + 1.47% per<br> year	1,385	1,731	1,681
	Second Issue of Promissory Notes - 2^nd^series			1,250,000	1,250,000	08/27/2021	02/27/2025	CDI + 1.53% per<br> year	1,387	1,734	1,683
	Third Issue of Debentures<br> - 1^st^ series<br> - CRI			982,526	982,526	10/15/2021	10/16/2028	IPCA + 5.15% per<br> year	1,176	1,155	1,122
	Third Issue of Debentures<br> - 2^nd^ series<br> - CRI			517,474	517,474	10/15/2021	10/15/2031	IPCA + 5.27% per<br> year	1,176	609	591
	Fourth Issue of Debentures<br> - single series			2,000,000	2,000,000	01/07/2022	11/26/2027	CDI + 1.75% per<br> year	1,043	2,086	2,024
	First Issue of Commercial Paper Notes -<br> single series			750,000	750,000	02/10/2022	02/09/2025	CDI + 1.70% per<br> year	1,015	761	790
	Fifth Issue of Debentures<br> - single series - CRI			250,000	250,000	04/05/2022	03/28/2025	CDI + 0.75% per<br> year	1,000	251	258
	Sixth Issue of Debentures<br> - 1^st^ series<br> - CRI			72,962	72,962	09/28/2022	09/11/2026	CDI + 0.60% per<br> year	1,004	73	76
	Sixth Issue of Debentures<br> - 2^nd^ series<br> - CRI			55,245	55,245	09/28/2022	09/13/2027	CDI + 0.70% per<br> year	1,004	56	58
	Sixth Issue of Debentures<br> - 3^rd^ series<br> - CRI			471,793	471,793	09/28/2022	09/13/2029	IPCA + 6.70% per<br> year	1,078	509	508
	Second Issue of Commercial Paper Notes<br> - single series			400,000	400,000	12/26/2022	12/26/2025	CDI + 0.93% per<br> year	1,176	471	458
	Seventh Issue of Debentures<br> - 1^st^ series<br> - CRI			145,721	145,721	07/25/2023	07/15/2026	CDI + 1.00% per<br> year	1,024	148	154
	Seventh Issue of Debentures<br> - 2^nd^ series<br> - CRI			878,503	878,503	07/25/2023	07/15/2027	Pré 11.75%<br> per year	1,023	898	921
	Seventh Issue of Debentures<br> - 3^rd^ series<br> - CRI			46,622	46,622	07/25/2023	07/17/2028	CDI + 1.15% per<br> year	1,024	49	50
	Eighth Issue of Debentures<br>- 1^st^ series			400,000	400,000	12/22/2023	12/22/2027	CDI + 1.85% per<br> year	1,033	412	401
	Eighth Issue of Debentures<br>- 2^nd^ series			400,000	400,000	12/22/2023	12/22/2028	CDI + 1.95% per<br> year	1,033	413	401
	Ninth Issue of Debentures<br> - single serie			500,000	500,000	03/28/2024	03/26/2029	CDI + 1.25% per<br> year	1,000	500	-
	Borrowing costs									(173)	(185)
										13,951	13,193
	The<br> Company issues debentures to strengthen its working capital, maintain its cash strategy, and lengthen its debt and investment profile.<br> The debentures issued are non-preemptive, non-convertible into shares, do not have renegotiation clauses and do not have guarantees.
15.7	Guarantees
	As<br> of March 31, 2024, the Company has no guarantees related to its borrowing agreement.
15.8	Swap<br> contracts
	The<br> Company uses swap operations for 100% of its borrowings denominated in fixed interest rates and IPCA, exchanging these liabilities<br> for the CDI (floating) interest rates. The annual average rate at CDI as of March 31, 2024 was 12.41% (13.04% as of December 31,<br> 2023).
15.9	Financial<br> covenants
	In<br> connection with the debentures and promissory notes issued, the Company is required to maintain certain financial ratios. These ratios<br> are calculated quarterly based on the Company’s interim financial information prepared in accordance with accounting practices<br> adopted in Brazil, as follows: (i) consolidated net debt / equity less than or equal to 3.00; and (ii) consolidated net debt/EBITDA<br> Last Twelve Months ("LTM") ratio should be lower than or equal to 3.00.
	As<br> of March 31, 2024, the Company had fulfilled all contractual obligations and was compliant with these ratios.
16	PROVISION FOR LEGAL PROCEEDINGS
---	---	---	---	---
	The provision for<br> legal proceedings is estimated by the Company and supported by its legal counsel and was established in an amount considered sufficient<br> to cover the considered probable losses.
		Social<br> security and labor	Civil	Total
	Balance as of December 31, 2022	86	24	165
	Additions	55	3	65
	Reversals	(6)	(2)	(8)
	Payments	(9)	(1)	(14)
	Monetary<br> correction	2	1	3
	Balance as of March 31, 2023	128	25	211
	Restricted deposits for legal proceedings	(25)	(9)	(35)
	Net provision for restricted deposits	103	16	176
		Social<br> security and labor	Civil	Total
	Balance as of December 31, 2023	163	38	263
	Additions	42	3	49
	Reversals	(15)	(1)	(47)
	Payments	(16)	(2)	(27)
	Monetary<br> correction	5	2	4
	Balance as of March 31, 2024	179	40	242
	Restricted deposits for legal proceedings	(12)	(10)	(23)
	Net provision for restricted deposits	167	30	219
	Of the total amount<br> of the table above, R45 (R50 as of December 31, 2023) is the responsibility of GPA arising from contingencies up to 2016, pursuant<br> to contractual provisions, namely: R3 tax claims, R20 labor claims and R22 civil claims (R3 tax claims, R27 labor claims and<br> R20 civil claims as of December 31, 2023).
16.1	Tax claims
	Tax claims are subject<br> by law to monthly monetary adjustment, which refers to an adjustment to the provision based on indexing rates adopted by each tax<br> jurisdiction. Both interest charges and fines, where applicable, were calculated and provisioned with respect to unpaid amounts.
	The Company has other<br> tax claims, which according to its legal counsel’s analysis, were provisioned, namely: (i) discussions on the non-application<br> of the Accident Prevention Factor (FAP); (ii) IPI in the resale of imported products; and (iii) other matters.
	The amount provisioned<br> for these matters as of March 31, 2024 is R23 (R62 as of December 31, 2023).
16.2	Social security and labor
	The Company is a<br> party to various labor proceedings, especially due to dismissals in the regular course of business. As of March 31, 2024, the Company<br> recorded a provision of R179 (R163 as of December 31, 2023), referring to a potential risk of loss relating to labor claims. Management,<br> with the assistance of its legal counsel, assesses these claims and records provisions for losses when reasonably estimated, considering<br> previous experiences in relation to amounts claimed.
16.3	Civil
	The Company is a<br> party to civil proceedings (indemnifications, collections, among others) that are in different procedural phases and at various courts.<br> Management records provisions in amounts considered sufficient to cover unfavorable court decisions when its internal and external<br> legal counsel assess the losses to be probable.
	Among these proceedings,<br> we highlight the following:
	The Company is a<br> party to various lawsuits requesting the renewal of rental agreements and the review of the current rent paid. The Company records<br> a provision for the difference between the monthly rental amounts originally paid by stores and the rental amounts calculated by<br> the legal experts considering that it is the expert report amount that will be used as the basis for the decision that will change<br> the rental amount paid by the entity. As of March 31, 2024, the amount of the provision for these lawsuits is R33 (R32 as of December<br> 31, 2023), for which there are no restricted deposits for legal proceedings.
	The Company is a<br> party to certain lawsuits relating to the fines applied by inspection bodies of direct and indirect administration of the federal<br> government, states, and municipalities, including consumer defense bodies (PROCONs, INMETRO, and local governments). The Company,<br> with the assistance of its legal counsel, assesses these claims recording provisions for probable cash disbursements according to<br> the estimate of loss. As of March 31, 2024, the amount of provision for these lawsuits is R7 (R6 as of December 31, 2023).

All values are in US Dollars.

	The Company’s<br> total civil, regulatory and property claims as of March 31, 2024, is R40 (R38 as of December 31, 2023).
16.4	Contingent liabilities<br> not accrued
	The Company is a<br> party to other litigations for which the risk of loss was classified by its legal counsel to be possible, therefore, not accrued,<br> which are related to:
			3/31/2024	12/31/2023
	Tax<br> on Financial Transactions (IOF) – payment differences.		14	14
	PIS,<br> COFINS – payment discrepancies and overpayments, fine for non-compliance with ancillary obligations, disallowance of PIS and<br> COFINS credits, among other matters pending judgment at the administrative and judicial levels.		734	783
	ICMS<br> – allocation of credits from purchases from suppliers considered unqualified by the registry of the State Revenue Service,<br> among other matters, which are pending judgment at the administrative and judicial levels.		1,162	1,216
	ISS<br> (services tax), IPTU (urban property tax), Fees and other – discrepancies in payments of IPTU, fines for non-compliance with<br> ancillary obligations, ISS – refund of advertising expenses and various fees, which are pending judgment at the administrative<br> and judicial levels.		20	18
	INSS<br> (national institute of social security) – divergences in the FGTS and Social Security form (GFIP), offsets not approved, among<br> other matters, which are pending judgment at the administrative and judicial levels.		25	24
	Other<br> litigation – real estate lawsuits in which the Company claims the renewal and maintenance of lease agreements according to<br> market prices. These lawsuits involve proceedings in civil court, as well as administrative proceedings filed by inspection bodies,<br> among others.		102	98
	Compensation<br> linked to the external legal counsel's success fee if all the proceedings were concluded in favor of the Company.		28	20
			2,085	2,173
	Of the total amount<br> in the table above, R1,176 (R1,494 as of December 31, 2023) is the responsibility of GPA arising from contingencies up to 2016,<br> pursuant to contractual provisions, namely: R1,075 tax claims and R101 civil claims (R1,398 tax claims and R96 civil claims as<br> of December 31, 2023).
	Three collective<br> proceedings were filed by institutions related to black people's movements due to an approach to a customer, in August 2021 at the<br> store in Limeira - SP, which claim supposed racial issues. All were duly answered. One of them has already been extinguished by the<br> judiciary without major effects. As of March 31, 2024, there are still two lawsuits in progress and, given the subjectivity of the<br> matter, it is still not possible to reasonably estimate the amounts involved. A significant impact on the interim financial information<br> is not expected.
16.4.1	Uncertainty<br> over IRPJ and CSLL treatments
	In compliance with ICPC 22/IFRIC 23 –<br> Uncertainty over Income Tax Treatment, the Company has proceedings, at the judicial and administrative levels, with Government's<br> regulatory agencies, which are related to uncertain tax treatments adopted for the recording of income tax and social contribution.<br> Based on the assessment of internal and external legal counsel, the tax treatment adopted by the Company is adequate, therefore,<br> these proceedings were classified as possible losses. As of March 31, 2024, the amount involved was R846 (R917 as of December 31,<br> 2023).
16.5	Guarantees
	The Company provided bank guarantees and<br> insurance guarantees for judicial proceedings of a civil, tax and labor nature, described below:
	Lawsuits	3/31/2023
	Tax	773
	Labor	88
	Civil<br> and others	488
		1,349
	The cost of guarantees as of March 31,<br> 2024 is approximately 0.20% per year of the amount of the lawsuits (0.30% as of March 31, 2023) and is recorded as a financial expense.
16.6	Restricted deposits for<br> legal proceedings
	The Company is challenging the payment<br> of certain taxes, contributions, and labor liabilities and made judicial deposits in amounts equivalent to the final court decisions,<br> as well as judicial deposits related to the provision for legal claims.
	The Company recorded amounts referring<br> to judicial deposits in its assets as follows.
	Lawsuits	12/31/2023
	Tax	18
	Labor	16
	Civil<br> and others	10
		44

All values are in US Dollars.

17	DEFERRED<br> REVENUES
			3/31/2024		12/31/2023
		Commercial agreement<br> with suppliers (i)	298		385
		Commercial agreement<br> - payroll (ii)	45		48
		Marketing and others	27		22
				370	455
		Current	336		418
		Non-current	34		37
	(i) Refers to rental<br> of supplier product exhibition modules "check stand", point of sale displays and backlight panels.
	(ii) Commercial agreement<br> with a financial institution for exclusivity in payroll processing.
18	INCOME<br> TAX AND SOCIAL CONTRIBUTION
18.1	Reconciliation<br> of income tax and social contribution expense
					3/31/2024		3/31/2023
		Income (loss) before income tax and social<br> contribution			54		(11)
		Expense of income tax and social contribution,<br> for nominal rate (34%)			(18)		4
		Adjustments to reflect the effective rate
		Tax fines			(2)		-
		Share of profits			6		4
		ICMS subsidy - tax incentives (i)			11		72
		Monetary correction credits			11		5
		Other permanent differences			(2)		(2)
		Effective income tax and social contribution			6		83
		Income tax and social contribution for the period
		Current			(27)		-
		Deferred			33		83
		Benefits of income tax and social contribution			6		83
		Effective rate			11.1%		-754.5%
	(i)<br> The Company calculates tax benefits that are characterized as tax incentives that, according to legal forecast, do not comprise the<br> basis for calculating income tax and social contribution.
18.2	Breakdown<br> of deferred income tax and social contribution
	The main components of<br> deferred income tax and social contribution in the balance sheets are the following:
				3/31/2024			12/31/2023
				Assets	Liabilities	Net	Assets	Liabilities	Net
	Deferred<br> income tax and social contribution
	Tax<br> losses			365	-	365	385	-	385
	Provision<br> for legal proceedings			74	-	74	81	-	81
	Swap			-	(77)	(77)	-	(66)	(66)
	Goodwill<br> tax amortization			-	(317)	(317)	-	(317)	(317)
	Mark-to-mark			-	(5)	(5)	-	(25)	(25)
	Property,<br> plant and equipment and intangible assets			25	-	25	25	-	25
	Unrealized<br> losses with tax credits			-	(3)	(3)	-	(15)	(15)
	Provision<br> of inventory			18	-	18	30	-	30
	Borrowing<br> costs			-	(59)	(59)	-	(66)	(66)
	Lease<br> net of right of use			3,091	(2,918)	173	3,071	(2,932)	139
	Gross<br> deferred income tax and social contribution assets (liabilities)			3,573	(3,379)	194	3,592	(3,421)	171
	Compensation			(3,379)	3,379	-	(3,421)	3,421	-
	Net<br> deferred income tax and social contribution assets (liabilities), net			194	-	194	171	-	171
	Management has assessed the future realization<br> of deferred tax assets, considering the projections of future taxable income, in the context of the main variables of its businesses.<br> This assessment was based on information from the strategic planning report previously approved by the Company´s Board of Directors.
---	---	---	---	---	---	---	---	---	---	---	---
	The Company estimates the recovery of<br> these credits as follows:
	Years		Amounts
	Within 1 year		201
	From 1 year to 2 years		264
	From 2 years to 3 years		1
	From 3 years to 4 years		1
	More than 5 years		3,106
			3,573
18.3	Roll forward of deferred<br> income tax and social contribution
				3/31/2024	3/31/2023
	At<br> the beginning of the period			171	6
	Benefits<br> in the period			33	83
	Income<br> tax effect			(1)	(1)
	Others			(9)		-
	At<br> the end of the period			194	88
19	SHAREHOLDERS’ EQUITY
19.1	Capital stock and stock<br> rights
	According to the Company's bylaws, the<br> Company's authorized capital may be increased up to 2 billion common shares. Below, the subscribed and fully paid-in share capital,<br> represented by common shares, all nominative and with no par value:
							Number<br> of shares		Amount
							1,349,165,394		1,263
							59,870		1
							1,031,232		1
							1,091,102		2
							1,350,256,496		1,265
							1,351,833,200		1,272
19.2	Tax incentive reserve
	Tax incentive reserves by the States were<br> considered investment subsidies, wich are deductible for the calculation of income tax and social contribution. Thus, for the year<br> ended December 31, 2023, the Company allocated the amount of R939 to the tax incentive reserve, of which R710 refers to the amount<br> of incentives generated in 2023 and constituted in the same year and R229 to be recognized when the Company reports income in subsequent<br> periods.
	As of March 31,<br> 2024, the Company recorded net profit in the amount of R60, this amount being fully allocated to the tax incentive reserve and R169<br> to be constituted as profits are determined in subsequent periods.
	Article 30 of<br> Law 12,973/2014 was revoked through Law 14,789/2023, releasing taxpayers from constituting a tax incentive reserve from January 1,<br> 2024.
19.3	Share-based payment
19.3.1	Recognized options granted
	Information relating to the Company's<br> Option Plan and Compensation Plan is summarized below:
								3/31/2024
								Number<br> of shares<br><br> (in thousands)
	Granted<br> series	Grant<br> date		1st<br> exercise date	Exercise<br> price on the grant date<br><br> (in reais)			Granted	Exercised	Cancelled	Current
	B8	5/31/2021		6/1/2024	0.01			363	(20)	(45)	298
	C8	5/31/2021		6/1/2024	13.39			363	(20)	(45)	298
	B9	5/31/2022		6/1/2025	0.01			2,163	(358)	-	1,805
	C9	5/31/2022		6/1/2025	12.53			1,924	(119)	-	1,805
	B10 (i)	5/31/2023		6/1/2026	0.01			1,390	-	-	1,390
	C10 (i)	5/31/2023		6/1/2026	11.82			1,390	-	-	1,390
								7,593	(517)	(90)	6,986

All values are in US Dollars.

	(i) Shares granted to<br> executives excluding statutory officers.
19.3.2	Consolidated<br> information of Company's share-based payment plans
	According to the plans,<br> the options granted in each of the series can represent a maximum of 2% of the total shares issued by the Company.
	The table below shows<br> the maximum percentage of dilution to which current shareholders could eventually be subject to in the event that all options granted<br> are exercised until March 31, 2024:
			3/31/2024
			(in<br> thousands)
	Number<br> of shares		1,351,833
	Balance<br> of effective series granted		6,986
	Maximum<br> percentage of dilution		0.52%
	The fair value of each<br> option granted is estimated on the grant date, using the options pricing model "Black-Scholes" taking into account the<br> following assumptions:
	Series<br> granted	Estimated<br> dividends	Approximate<br> estimated volatility	Risk-free<br> weighted average interest rate	Average<br> remaining life expectancy
	B8	1.28%	37.06%	7.66%	2<br> months
	C8
	B9	1.20%	37.29%	12.18%	14<br> months
	C9
	B10	1.31%	35.32%	10.87%	26<br> months
	C10
			Shares	Weighted<br> average exercise price
			in<br> thousands	R
	As of December 31,<br> 2023		6,986	5.97
	Outstanding<br> at the end of the period		6,986	5.97
	Total to be exercised<br> as of March 31, 2024		6,986	5.97
	The amount recorded in<br> the statement of operations for the period ended March 31, 2024 was R7 (R10 as of March 31, 2023).
19.3.3	Cash-settled<br> share-based payment plan
	At the Extraordinary<br> General Meeting held on July 14, 2023, the cash-settled share-based payment plan was approved, only for the Company's Statutory Officers,<br> this plan does not make officers a partner of the Company, they only acquire the right to receive a cash compensation corresponding<br> to the average price of the Company's shares traded on B3 under the ticker ASAI3.
	1,989,465 shares were<br> granted to the Company's officers and the premium related to 50% of the shares will be conditional on compliance with the service<br> condition (shares conditioned on time) and the other 50% of the shares will be conditional on the cumulative compliance with the<br> service condition and the performance condition (shares conditioned on time and performance).
	For shares conditioned<br> on time to become vested, Offices must remain with the Company from the grant date to the dates below (vesting period):
	a) 20% (twenty percent)<br> on the 3-year anniversary from the grant date;<br> b) 20% (twenty percent) on the 4-year anniversary from the grant date; and<br> c) 60% (sixty percent) on the 5-year anniversary from the grant date.
	For shares conditioned<br> on time and performance to become vested, the Executive must comply with the vesting periods above, in addition to meeting the goals,<br> being segregated between: a) Environmental, Social and Governance ("ESG") goal with a weight of 30 %: i) hiring people<br> with disabilities; ii) women in leadership, in managerial positions or higher; and iii) total carbon emissions – Scope 1 and<br> 2; and b) Operating target with a weight of 70%: i) operating cash flow.
	The targets above will<br> be reviewed annually by the Board of Directors and non-achievement of them at December 31, 2026 and 2027 may be compensated by achievement<br> on subsequent measurement dates.
	As of March 31, 2024,<br> the amount of the liability corresponding to the plan, including payroll charges, in recorded is "Other accounts payable"<br> in the amount of R7 (R4 as of December 31, 2023) and the total expense recognized, including payroll charges, was R3 (zero as<br> of March 31, 2023) and the fair value of this plan in that date was R39, including charges.

All values are in US Dollars.

20	NET OPERATING<br> REVENUE
			3/31/2024		3/31/2023
		Gross operating revenue
		Goods	18,762		16,513
		Services<br> rendered and others	64		54
			18,826		16,567
		(-) Revenue deductions
		Returns<br> and sales cancellation	(39)		(29)
		Taxes	(1,565)		(1,442)
			(1,604)		(1,471)
		Net operating revenue	17,222		15,096
21	EXPENSES<br> BY NATURE
			3/31/2024		3/31/2023
	Inventory cost		(14,166)		(12,460)
	Personnel expenses		(1,059)		(976)
	Outsourced services		(92)		(88)
	Selling expenses		(267)		(229)
	Functional expenses		(329)		(290)
	Other expenses		(128)		(137)
			(16,041)		(14,180)
	Cost of sales		(14,420)		(12,668)
	Selling expenses		(1,416)		(1,306)
	General and administrative expenses		(205)		(206)
			(16,041)		(14,180)
22	OTHER<br> OPERATING (EXPENSES) REVENUES, NET
				3/31/2024		3/31/2023
	Result with property, plant and equipment<br> and leases			(4)		6
	Restructuring expenses and others			-		(2)
				(4)		4
23	NET FINANCIAL<br> RESULT
				3/31/2024		3/31/2023
		Financial revenues
		Cash<br> and cash equivalents interest		16		43
		Monetary<br> correction assets		9		16
		Revenue<br> from anticipation of payables		15		8
		Other<br> financial revenues		3		3
		Total financial revenues		43		70
		Financial expenses
		Cost<br> of debt		(451)		(396)
		Mark-to-market<br> (loss) gain		(58)		19
		Cost<br> and discount of receivables		(45)		(26)
		Monetary<br> correction liabilities		3		(93)
		Interest<br> on lease liabilities		(250)		(202)
		Other<br> financial expenses		(2)		(2)
		Total financial expenses		(803)		(700)
				(760)		(630)
24	EARNINGS PER SHARE
---	---	---	---	---	---
	The Company calculates<br> earnings per share by dividing the net income for the period, relating to each class of shares, by the total number of common shares<br> outstanding in the period.
	The table below presents the determination<br> of the net income for the period available to holders of outstanding common shares to calculate the basic earnings and diluted earnings<br> per share in each period presented:
		3/31/2024	3/31/2023
	Net<br> income allocated available to holders of common shares (a)	60	72		#REF!
	Weighted<br> average of the number of shares	1,352	1,349
	Basic<br> denominator (million of shares) (b)	1,352	1,349
	Weighted<br> average of stock option	3	4		#REF!
	Diluted<br> denominator (million of shares) (c)	1,355	1,353
	Basic<br> earnings per million shares (R$) (a ÷ b)	0.044747	0.053296
	Diluted<br> earnings per million shares (R$) (a ÷ c)	0.044646	0.053141
25	NON-CASH TRANSACTIONS
	The Company had transactions that did<br> not represent cash disbursements, and, therefore, these were not presented in the Statement of Cash Flows, as follows:
	Transactions			Note
	Acquisition<br> of property, plant and equipment not yet paid			11.3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 24, 2024

Sendas Distribuidora S.A.

By: /s/ Vitor Fagá de Almeida

Name: Vitor Fagá de Almeida

Title: Vice-President of Finance and Investor Relations

By: /s/ Gabrielle Helú

Name: Gabrielle Helú

Title: Investor Relations Officer

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.